Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol. 2014; 40(6):572-81.

View in: PubMed

subject areas

Aged
Albuminuria
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Blood Pressure
Creatinine
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Double-Blind Method
Familial Primary Pulmonary Hypertension
Female
Glomerular Filtration Rate
Humans
Male
Middle Aged
Mineralocorticoid Receptor Antagonists
Naphthyridines
Potassium